Blood Screening Market Size, Share & Trends Report

Blood Screening Market (2025 - 2030) Size, Share & Trends Analysis Report By Technology (Nucleic Acid Amplification Test, ELISA, Western Blotting), By Product (Reagent, Instrument), By Region, And Segment Forecasts

Market Segmentation

Blood Screening Technology Outlook (Revenue, USD Million, 2018 - 2030)
- Nucleic Acid Amplification Test (NAT)
- ELISA
- Chemiluminescence Immunoassay (CLIA & EIA )
- Next Generation Sequencing (NGS)
- Western Blotting (WB)
Blood Screening Product Outlook (Revenue, USD Million, 2018 - 2030)
- Reagent
- Instrument
Blood Screening Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
  - North America Blood Screening Market, by Technology
    - Nucleic Acid Amplification Test (NAT)
    - ELISA
    - Chemiluminescence Immunoassay (CLIA & EIA )
    - Next Generation Sequencing (NGS)
    - Western Blotting (WB)
  - North America Blood Screening Market, by Product
    - Reagent
    - Instrument
  - U.S.
    - U.S. Blood Screening Market, by Technology
      - Nucleic Acid Amplification Test (NAT)
      - ELISA
      - Chemiluminescence Immunoassay (CLIA & EIA )
      - Next Generation Sequencing (NGS)
      - Western Blotting (WB)
    - U.S. Blood Screening Market, by Product
      - Reagent
      - Instrument
  - Canada
    - Canada Blood Screening Market, by Technology
      - Nucleic Acid Amplification Test (NAT)
      - ELISA
      - Chemiluminescence Immunoassay (CLIA & EIA )
      - Next Generation Sequencing (NGS)
      - Western Blotting (WB)
    - Canada Blood Screening Market, by Product
      - Reagent
      - Instrument
  - Mexico
    - Mexico Blood Screening Market, by Technology
      - Nucleic Acid Amplification Test (NAT)
      - ELISA
      - Chemiluminescence Immunoassay (CLIA & EIA )
      - Next Generation Sequencing (NGS)
      - Western Blotting (WB)
    - Mexico Blood Screening Market, by Product
      - Reagent
      - Instrument
- Europe
  - Europe Blood Screening Market, by Technology
    - Nucleic Acid Amplification Test (NAT)
    - ELISA
    - Chemiluminescence Immunoassay (CLIA & EIA )
    - Next Generation Sequencing (NGS)
    - Western Blotting (WB)
  - Europe Blood Screening Market, by Product
    - Reagent
    - Instrument
  - UK
    - UK Blood Screening Market, by Technology
      - Nucleic Acid Amplification Test (NAT)
      - ELISA
      - Chemiluminescence Immunoassay (CLIA & EIA )
      - Next Generation Sequencing (NGS)
      - Western Blotting (WB)
    - UK Blood Screening Market, by Product
      - Reagent
      - Instrument
  - Germany
    - Germany Blood Screening Market, by Technology
      - Nucleic Acid Amplification Test (NAT)
      - ELISA
      - Chemiluminescence Immunoassay (CLIA & EIA )
      - Next Generation Sequencing (NGS)
      - Western Blotting (WB)
    - Germany Blood Screening Market, by Product
      - Reagent
      - Instrument
  - France
    - France Blood Screening Market, by Technology
      - Nucleic Acid Amplification Test (NAT)
      - ELISA
      - Chemiluminescence Immunoassay (CLIA & EIA )
      - Next Generation Sequencing (NGS)
      - Western Blotting (WB)
    - France Blood Screening Market, by Product
      - Reagent
      - Instrument
  - Italy
    - Italy Blood Screening Market, by Technology
      - Nucleic Acid Amplification Test (NAT)
      - ELISA
      - Chemiluminescence Immunoassay (CLIA & EIA )
      - Next Generation Sequencing (NGS)
      - Western Blotting (WB)
    - Italy Blood Screening Market, by Product
      - Reagent
      - Instrument
  - Spain
    - Spain Blood Screening Market, by Technology
      - Nucleic Acid Amplification Test (NAT)
      - ELISA
      - Chemiluminescence Immunoassay (CLIA & EIA )
      - Next Generation Sequencing (NGS)
      - Western Blotting (WB)
    - Spain Blood Screening Market, by Product
      - Reagent
      - Instrument
  - Norway
    - Norway Blood Screening Market, by Technology
      - Nucleic Acid Amplification Test (NAT)
      - ELISA
      - Chemiluminescence Immunoassay (CLIA & EIA )
      - Next Generation Sequencing (NGS)
      - Western Blotting (WB)
    - Norway Blood Screening Market, by Product
      - Reagent
      - Instrument
  - Denmark
    - Denmark Blood Screening Market, by Technology
      - Nucleic Acid Amplification Test (NAT)
      - ELISA
      - Chemiluminescence Immunoassay (CLIA & EIA )
      - Next Generation Sequencing (NGS)
      - Western Blotting (WB)
    - Denmark Blood Screening Market, by Product
      - Reagent
      - Instrument
  - Sweden
    - Sweden Blood Screening Market, by Technology
      - Nucleic Acid Amplification Test (NAT)
      - ELISA
      - Chemiluminescence Immunoassay (CLIA & EIA )
      - Next Generation Sequencing (NGS)
      - Western Blotting (WB)
    - Sweden Blood Screening Market, by Product
      - Reagent
      - Instrument
- Asia Pacific
  - Asia Pacific Blood Screening Market, by Technology
    - Nucleic Acid Amplification Test (NAT)
    - ELISA
    - Chemiluminescence Immunoassay (CLIA & EIA )
    - Next Generation Sequencing (NGS)
    - Western Blotting (WB)
  - Asia Pacific Blood Screening Market, by Product
    - Reagent
    - Instrument
  - Japan
    - Japan Blood Screening Market, by Technology
      - Nucleic Acid Amplification Test (NAT)
      - ELISA
      - Chemiluminescence Immunoassay (CLIA & EIA )
      - Next Generation Sequencing (NGS)
      - Western Blotting (WB)
    - Japan Blood Screening Market, by Product
      - Reagent
      - Instrument
  - China
    - China Blood Screening Market, by Technology
      - Nucleic Acid Amplification Test (NAT)
      - ELISA
      - Chemiluminescence Immunoassay (CLIA & EIA )
      - Next Generation Sequencing (NGS)
      - Western Blotting (WB)
    - China Blood Screening Market, by Product
      - Reagent
      - Instrument
  - India
    - India Blood Screening Market, by Technology
      - Nucleic Acid Amplification Test (NAT)
      - ELISA
      - Chemiluminescence Immunoassay (CLIA & EIA )
      - Next Generation Sequencing (NGS)
      - Western Blotting (WB)
    - India Blood Screening Market, by Product
      - Reagent
      - Instrument
  - Australia
    - Australia Blood Screening Market, by Technology
      - Nucleic Acid Amplification Test (NAT)
      - ELISA
      - Chemiluminescence Immunoassay (CLIA & EIA )
      - Next Generation Sequencing (NGS)
      - Western Blotting (WB)
    - Australia Blood Screening Market, by Product
      - Reagent
      - Instrument
  - South Korea
    - South Korea Blood Screening Market, by Technology
      - Nucleic Acid Amplification Test (NAT)
      - ELISA
      - Chemiluminescence Immunoassay (CLIA & EIA )
      - Next Generation Sequencing (NGS)
      - Western Blotting (WB)
    - South Korea Blood Screening Market, by Product
      - Reagent
      - Instrument
  - Thailand
    - Thailand Blood Screening Market, by Technology
      - Nucleic Acid Amplification Test (NAT)
      - ELISA
      - Chemiluminescence Immunoassay (CLIA & EIA )
      - Next Generation Sequencing (NGS)
      - Western Blotting (WB)
    - Thailand Blood Screening Market, by Product
      - Reagent
      - Instrument
- Latin America
  - Latin America Blood Screening Market, by Technology
    - Nucleic Acid Amplification Test (NAT)
    - ELISA
    - Chemiluminescence Immunoassay (CLIA & EIA )
    - Next Generation Sequencing (NGS)
    - Western Blotting (WB)
  - Latin America Blood Screening Market, by Product
    - Reagent
    - Instrument
  - Brazil
    - Brazil Blood Screening Market, by Technology
      - Nucleic Acid Amplification Test (NAT)
      - ELISA
      - Chemiluminescence Immunoassay (CLIA & EIA )
      - Next Generation Sequencing (NGS)
      - Western Blotting (WB)
    - Brazil Blood Screening Market, by Product
      - Reagent
      - Instrument
  - Argentina
    - Argentina Blood Screening Market, by Technology
      - Nucleic Acid Amplification Test (NAT)
      - ELISA
      - Chemiluminescence Immunoassay (CLIA & EIA )
      - Next Generation Sequencing (NGS)
      - Western Blotting (WB)
    - Argentina Blood Screening Market, by Product
      - Reagent
      - Instrument
- MEA
  - MEA Blood Screening Market, by Technology
    - Nucleic Acid Amplification Test (NAT)
    - ELISA
    - Chemiluminescence Immunoassay (CLIA & EIA )
    - Next Generation Sequencing (NGS)
    - Western Blotting (WB)
  - MEA Blood Screening Market, by Product
    - Reagent
    - Instrument
  - South Africa
    - South Africa Blood Screening Market, by Technology
      - Nucleic Acid Amplification Test (NAT)
      - ELISA
      - Chemiluminescence Immunoassay (CLIA & EIA )
      - Next Generation Sequencing (NGS)
      - Western Blotting (WB)
    - South Africa Blood Screening Market, by Product
      - Reagent
      - Instrument
  - Saudi Arabia
    - Saudi Arabia Blood Screening Market, by Technology
      - Nucleic Acid Amplification Test (NAT)
      - ELISA
      - Chemiluminescence Immunoassay (CLIA & EIA )
      - Next Generation Sequencing (NGS)
      - Western Blotting (WB)
    - Saudi Arabia Blood Screening Market, by Product
      - Reagent
      - Instrument
  - UAE
    - UAE Blood Screening Market, by Technology
      - Nucleic Acid Amplification Test (NAT)
      - ELISA
      - Chemiluminescence Immunoassay (CLIA & EIA )
      - Next Generation Sequencing (NGS)
      - Western Blotting (WB)
    - UAE Blood Screening Market, by Product
      - Reagent
      - Instrument
  - Kuwait
    - Kuwait Blood Screening Market, by Technology
      - Nucleic Acid Amplification Test (NAT)
      - ELISA
      - Chemiluminescence Immunoassay (CLIA & EIA )
      - Next Generation Sequencing (NGS)
      - Western Blotting (WB)
    - Kuwait Blood Screening Market, by Product
      - Reagent
      - Instrument

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments